Table of Content

Table of Contents

Global Ticarcillin Disodium and Clavulanate Potassium For Injection Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Ticarcillin Disodium and Clavulanate Potassium For Injection Market by Value
2.2.1 Global Ticarcillin Disodium and Clavulanate Potassium For Injection Revenue by Type
2.2.2 Global Ticarcillin Disodium and Clavulanate Potassium For Injection Market by Value (%)
2.3 Global Ticarcillin Disodium and Clavulanate Potassium For Injection Market by Production
2.3.1 Global Ticarcillin Disodium and Clavulanate Potassium For Injection Production by Type
2.3.2 Global Ticarcillin Disodium and Clavulanate Potassium For Injection Market by Production (%)

3. The Major Driver of Ticarcillin Disodium and Clavulanate Potassium For Injection Industry
3.1 Historical & Forecast Global Ticarcillin Disodium and Clavulanate Potassium For Injection Demand
3.2 Largest Application for Ticarcillin Disodium and Clavulanate Potassium For Injection (2018-2028)
3.3 The Major Downstream Company in China Market 2022

4. Global and Regional Ticarcillin Disodium and Clavulanate Potassium For Injection Market
4.1 Regional Market Size in Terms of Production & Demand (2022)
4.2 Regional Market Share in Terms of Revenue (2018-2022)
4.3 Concentration Ratio (CR5& CR10) of Ticarcillin Disodium and Clavulanate Potassium For Injection Market
4.4 Mergers & Acquisitions, Expansion Plans

5. US Ticarcillin Disodium and Clavulanate Potassium For Injection Production, Revenue (2018-2028)
5.1 Current and Estimated Production Breakdown by Type
5.2 Current and Estimated Production Breakdown by Application
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

6. Europe Ticarcillin Disodium and Clavulanate Potassium For Injection Production, Revenue (2018-2028)
6.1 Current and Estimated Production Breakdown by Type
6.2 Current and Estimated Production Breakdown by Application
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

7. China Ticarcillin Disodium and Clavulanate Potassium For Injection Production, Revenue (2018-2028)
7.1 Current and Estimated Production Breakdown by Type
7.2 Current and Estimated Production Breakdown by Application
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

8. Japan Ticarcillin Disodium and Clavulanate Potassium For Injection Production, Revenue (2018-2028)
8.1 Current and Estimated Production Breakdown by Type
8.2 Current and Estimated Production Breakdown by Application
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

9. India Ticarcillin Disodium and Clavulanate Potassium For Injection Production, Revenue (2018-2028)
9.1 Current and Estimated Production Breakdown by Type
9.2 Current and Estimated Production Breakdown by Application
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

10. Korea Ticarcillin Disodium and Clavulanate Potassium For Injection Production, Revenue (2018-2028)
10.1 Current and Estimated Production Breakdown by Type
10.2 Current and Estimated Production Breakdown by Application
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

11. Southeast Asia Ticarcillin Disodium and Clavulanate Potassium For Injection Production, Revenue (2018-2028)
11.1 Current and Estimated Production Breakdown by Type
11.2 Current and Estimated Production Breakdown by Application
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

12. Global Ticarcillin Disodium and Clavulanate Potassium For Injection Average Price Trend
12.1 Market Price for Each Type of Ticarcillin Disodium and Clavulanate Potassium For Injection in US (2018-2022)
12.2 Market Price for Each Type of Ticarcillin Disodium and Clavulanate Potassium For Injection in Europe (2018-2022)
12.3 Market Price for Each Type of Ticarcillin Disodium and Clavulanate Potassium For Injection in China (2018-2022)
12.4 Market Price for Each Type of Ticarcillin Disodium and Clavulanate Potassium For Injection in Japan (2018-2022)
12.5 Market Price for Each Type of Ticarcillin Disodium and Clavulanate Potassium For Injection in India (2018-2022)
12.6 Market Price for Each Type of Ticarcillin Disodium and Clavulanate Potassium For Injection in Korea (2018-2022)
12.7 Market Price for Each Type of Ticarcillin Disodium and Clavulanate Potassium For Injection in Southeast Asia (2018-2022)

13. Industrial Chain (Impact of COVID-19)
13.1 Ticarcillin Disodium and Clavulanate Potassium For Injection Industrial Chain Analysis
13.2 Downstream
13.3 Impact of COVID-19
13.4 Post-pandemic Era
13.5 Technology Trends of Ticarcillin Disodium and Clavulanate Potassium For Injection

14. Ticarcillin Disodium and Clavulanate Potassium For Injection Competitive Landscape
14.1 GlaxoSmithKline
14.1.1 GlaxoSmithKline Company Profiles
14.1.2 GlaxoSmithKline Product Introduction
14.1.3 GlaxoSmithKline Ticarcillin Disodium and Clavulanate Potassium For Injection Production, Revenue (2018-2022)
14.1.4 Strategic initiatives
14.2 United Biotech Pvt Ltd
14.2.1 United Biotech Pvt Ltd Company Profiles
14.2.2 United Biotech Pvt Ltd Product Introduction
14.2.3 United Biotech Pvt Ltd Ticarcillin Disodium and Clavulanate Potassium For Injection Production, Revenue (2018-2022)
14.2.4 Strategic initiatives
14.3 Shandong Lukang Pharmaceutical Co., Ltd.
14.3.1 Shandong Lukang Pharmaceutical Co., Ltd. Company Profiles
14.3.2 Shandong Lukang Pharmaceutical Co., Ltd. Product Introduction
14.3.3 Shandong Lukang Pharmaceutical Co., Ltd. Ticarcillin Disodium and Clavulanate Potassium For Injection Production, Revenue (2018-2022)
14.3.4 Strategic initiatives
14.4 Jiangsu Haihong Pharmaceutical Co., Ltd.
14.4.1 Jiangsu Haihong Pharmaceutical Co., Ltd. Company Profiles
14.4.2 Jiangsu Haihong Pharmaceutical Co., Ltd. Product Introduction
14.4.3 Jiangsu Haihong Pharmaceutical Co., Ltd. Ticarcillin Disodium and Clavulanate Potassium For Injection Production, Revenue (2018-2022)
14.4.4 Strategic initiatives
14.5 Southwest Pharmaceutical Co., Ltd.
14.5.1 Southwest Pharmaceutical Co., Ltd. Company Profiles
14.5.2 Southwest Pharmaceutical Co., Ltd. Product Introduction
14.5.3 Southwest Pharmaceutical Co., Ltd. Ticarcillin Disodium and Clavulanate Potassium For Injection Production, Revenue (2018-2022)
14.5.4 Strategic initiatives
14.6 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd.
14.6.1 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Company Profiles
14.6.2 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Product Introduction
14.6.3 Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Ticarcillin Disodium and Clavulanate Potassium For Injection Production, Revenue (2018-2022)
14.6.4 Strategic initiatives
14.7 Ruiyang Pharmaceutical Co., Ltd.
14.7.1 Ruiyang Pharmaceutical Co., Ltd. Company Profiles
14.7.2 Ruiyang Pharmaceutical Co., Ltd. Product Introduction
14.7.3 Ruiyang Pharmaceutical Co., Ltd. Ticarcillin Disodium and Clavulanate Potassium For Injection Production, Revenue (2018-2022)
14.7.4 Strategic initiatives
14.8 Hainan Beautiful Xilin Biopharmaceutical Co., Ltd.
14.8.1 Hainan Beautiful Xilin Biopharmaceutical Co., Ltd. Company Profiles
14.8.2 Hainan Beautiful Xilin Biopharmaceutical Co., Ltd. Product Introduction
14.8.3 Hainan Beautiful Xilin Biopharmaceutical Co., Ltd. Ticarcillin Disodium and Clavulanate Potassium For Injection Production, Revenue (2018-2022)
14.8.4 Strategic initiatives
14.9 Shanghai Shangyao Xinya Pharmaceutical Co., Ltd.
14.9.1 Shanghai Shangyao Xinya Pharmaceutical Co., Ltd. Company Profiles
14.9.2 Shanghai Shangyao Xinya Pharmaceutical Co., Ltd. Product Introduction
14.9.3 Shanghai Shangyao Xinya Pharmaceutical Co., Ltd. Ticarcillin Disodium and Clavulanate Potassium For Injection Production, Revenue (2018-2022)
14.9.4 Strategic initiatives
14.10 Tianjin Huajin Pharmaceutical Co., Ltd.
14.10.1 Tianjin Huajin Pharmaceutical Co., Ltd. Company Profiles
14.10.2 Tianjin Huajin Pharmaceutical Co., Ltd. Product Introduction
14.10.3 Tianjin Huajin Pharmaceutical Co., Ltd. Ticarcillin Disodium and Clavulanate Potassium For Injection Production, Revenue (2018-2022)
14.10.4 Strategic initiatives
14.11 Langzhi Group Bokang Pharmaceutical Co., Ltd.
14.12 Suzhou Erye Pharmaceutical Co., Ltd.
15. Conclusion
16. Methodology and Data Source

List of Figure

List of Tables and Figures

Figure 1. Total Demand by Application of Ticarcillin Disodium and Clavulanate Potassium For Injection Industry (Volume)
Figure 2. Ticarcillin Disodium and Clavulanate Potassium For Injection Production & Demand by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2027)
Figure 4. The Top 10 and 5 Players Market Share by Ticarcillin Disodium and Clavulanate Potassium For Injection Revenue in 2022
Figure 5. US Ticarcillin Disodium and Clavulanate Potassium For Injection Production, Demand (2018-2028)
Figure 6. Production Breakdown by Type (%)
Figure 7. Demand Breakdown by Type (%)
Figure 8. Demand Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Ticarcillin Disodium and Clavulanate Potassium For Injection Production, Demand (2018-2028)
Figure 12. Production Breakdown by Type (%)
Figure 13. Demand Breakdown by Type (%)
Figure 14. Demand Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Ticarcillin Disodium and Clavulanate Potassium For Injection Production, Demand (2018-2028)
Figure 18. Production Breakdown by Type (%)
Figure 19. Demand Breakdown by Type (%)
Figure 20. Demand Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Ticarcillin Disodium and Clavulanate Potassium For Injection Production, Demand (2018-2028)
Figure 25. Production Breakdown by Type (%)
Figure 26. Demand Breakdown by Type (%)
Figure 27. Demand Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Ticarcillin Disodium and Clavulanate Potassium For Injection Production, Demand (2018-2028)
Figure 31. Production Breakdown by Type (%)
Figure 32. Demand Breakdown by Type (%)
Figure 33. Demand Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Ticarcillin Disodium and Clavulanate Potassium For Injection Production, Demand (2018-2028)
Figure 37. Production Breakdown by Type (%)
Figure 38. Demand Breakdown by Type (%)
Figure 39. Demand Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Ticarcillin Disodium and Clavulanate Potassium For Injection Production, Demand (2018-2028)
Figure 43. Current and Estimated Production Breakdown by Type (2018-2028)
Figure 44. Production Breakdown by Type (%)
Figure 45. Demand Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Ticarcillin Disodium and Clavulanate Potassium For Injection Revenue, by Type (Million USD) (2018-2028)
Table 4. Ticarcillin Disodium and Clavulanate Potassium For Injection Production, by Type (K Unit) (2018-2028)
Table 5. Ticarcillin Disodium and Clavulanate Potassium For Injection Demand (K Unit) by Application (2018-2028)
Table 6. Ticarcillin Disodium and Clavulanate Potassium For Injection Demand (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Production & Demand (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2027)
Table 10. Ranking of Global Top Ticarcillin Disodium and Clavulanate Potassium For Injection Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Ticarcillin Disodium and Clavulanate Potassium For Injection Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 13. Current and Estimated Production Breakdown by Type (2018-2028)
Table 14. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 15. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Ticarcillin Disodium and Clavulanate Potassium For Injection Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 19. Current and Estimated Production Breakdown by Type (2018-2028)
Table 20. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 21. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Ticarcillin Disodium and Clavulanate Potassium For Injection Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 25. Table Current and Estimated Production Breakdown by Type
Table 26. Current and Estimated Demand Breakdown by Type
Table 27. Current and Estimated Demand Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Ticarcillin Disodium and Clavulanate Potassium For Injection Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 30. Current and Estimated Production Breakdown by Type (2018-2028)
Table 31. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 32. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Ticarcillin Disodium and Clavulanate Potassium For Injection Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 36. Current and Estimated Production Breakdown by Type (2018-2028)
Table 37. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 38. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Ticarcillin Disodium and Clavulanate Potassium For Injection Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 42. Current and Estimated Production Breakdown by Type (2018-2028)
Table 43. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 44. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Ticarcillin Disodium and Clavulanate Potassium For Injection Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 48. Table Current and Estimated Demand Breakdown by Type (2018-2028)
Table 49. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Ticarcillin Disodium and Clavulanate Potassium For Injection in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of Ticarcillin Disodium and Clavulanate Potassium For Injection in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of Ticarcillin Disodium and Clavulanate Potassium For Injection in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of Ticarcillin Disodium and Clavulanate Potassium For Injection in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of Ticarcillin Disodium and Clavulanate Potassium For Injection in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of Ticarcillin Disodium and Clavulanate Potassium For Injection in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of Ticarcillin Disodium and Clavulanate Potassium For Injection in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. GlaxoSmithKline Profiles
Table 61. GlaxoSmithKline Ticarcillin Disodium and Clavulanate Potassium For Injection Product Introduction
Table 62. GlaxoSmithKline Ticarcillin Disodium and Clavulanate Potassium For Injection Production (Unit), Revenue (Million USD) (2018-2022)
Table 63. GlaxoSmithKline Strategic initiatives
Table 64. United Biotech Pvt Ltd Profiles
Table 65. United Biotech Pvt Ltd Ticarcillin Disodium and Clavulanate Potassium For Injection Product Introduction
Table 66. United Biotech Pvt Ltd Ticarcillin Disodium and Clavulanate Potassium For Injection Production (Unit), Revenue (Million USD) (2018-2022)
Table 67. United Biotech Pvt Ltd Strategic initiatives
Table 68. Shandong Lukang Pharmaceutical Co., Ltd. Profiles
Table 69. Shandong Lukang Pharmaceutical Co., Ltd. Ticarcillin Disodium and Clavulanate Potassium For Injection Product Introduction
Table 70. Shandong Lukang Pharmaceutical Co., Ltd. Ticarcillin Disodium and Clavulanate Potassium For Injection Production (Unit), Revenue (Million USD) (2018-2022)
Table 71. Shandong Lukang Pharmaceutical Co., Ltd. Strategic initiatives
Table 72. Jiangsu Haihong Pharmaceutical Co., Ltd. Profiles
Table 73. Jiangsu Haihong Pharmaceutical Co., Ltd. Ticarcillin Disodium and Clavulanate Potassium For Injection Product Introduction
Table 74. Jiangsu Haihong Pharmaceutical Co., Ltd. Ticarcillin Disodium and Clavulanate Potassium For Injection Production (Unit), Revenue (Million USD) (2018-2022)
Table 75. Jiangsu Haihong Pharmaceutical Co., Ltd. Strategic initiatives
Table 76. Southwest Pharmaceutical Co., Ltd. Profiles
Table 77. Southwest Pharmaceutical Co., Ltd. Ticarcillin Disodium and Clavulanate Potassium For Injection Product Introduction
Table 78. Southwest Pharmaceutical Co., Ltd. Ticarcillin Disodium and Clavulanate Potassium For Injection Production (Unit), Revenue (Million USD) (2018-2022)
Table 79. Southwest Pharmaceutical Co., Ltd. Strategic initiatives
Table 80. Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Profiles
Table 81. Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Ticarcillin Disodium and Clavulanate Potassium For Injection Product Introduction
Table 82. Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Ticarcillin Disodium and Clavulanate Potassium For Injection Production (Unit), Revenue (Million USD) (2018-2022)
Table 83. Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. Strategic initiatives
Table 84. Ruiyang Pharmaceutical Co., Ltd. Profiles
Table 85. Ruiyang Pharmaceutical Co., Ltd. Ticarcillin Disodium and Clavulanate Potassium For Injection Product Introduction
Table 86. Ruiyang Pharmaceutical Co., Ltd. Ticarcillin Disodium and Clavulanate Potassium For Injection Production (Unit), Revenue (Million USD) (2018-2022)
Table 87. Ruiyang Pharmaceutical Co., Ltd. Strategic initiatives
Table 88. Hainan Beautiful Xilin Biopharmaceutical Co., Ltd. Profiles
Table 89. Hainan Beautiful Xilin Biopharmaceutical Co., Ltd. Ticarcillin Disodium and Clavulanate Potassium For Injection Product Introduction
Table 90. Hainan Beautiful Xilin Biopharmaceutical Co., Ltd. Ticarcillin Disodium and Clavulanate Potassium For Injection Production (Unit), Revenue (Million USD) (2018-2022)
Table 91. Hainan Beautiful Xilin Biopharmaceutical Co., Ltd. Strategic initiatives
Table 92. Shanghai Shangyao Xinya Pharmaceutical Co., Ltd. Profiles
Table 93. Shanghai Shangyao Xinya Pharmaceutical Co., Ltd. Ticarcillin Disodium and Clavulanate Potassium For Injection Product Introduction
Table 94. Shanghai Shangyao Xinya Pharmaceutical Co., Ltd. Ticarcillin Disodium and Clavulanate Potassium For Injection Production (Unit), Revenue (Million USD) (2018-2022)
Table 95. Shanghai Shangyao Xinya Pharmaceutical Co., Ltd. Strategic initiatives
Table 97. Tianjin Huajin Pharmaceutical Co., Ltd. Profiles
Table 98. Tianjin Huajin Pharmaceutical Co., Ltd. Ticarcillin Disodium and Clavulanate Potassium For Injection Product Introduction
Table 99. Tianjin Huajin Pharmaceutical Co., Ltd. Ticarcillin Disodium and Clavulanate Potassium For Injection Production (Unit), Revenue (Million USD) (2018-2022)
Table 100. Tianjin Huajin Pharmaceutical Co., Ltd. Strategic initiatives
Table 101. Langzhi Group Bokang Pharmaceutical Co., Ltd. Profiles
Table 102. Langzhi Group Bokang Pharmaceutical Co., Ltd. Ticarcillin Disodium and Clavulanate Potassium For Injection Product Introduction
Table 103. Langzhi Group Bokang Pharmaceutical Co., Ltd. Ticarcillin Disodium and Clavulanate Potassium For Injection Production (Unit), Revenue (Million USD) (2018-2022)
Table 104. Langzhi Group Bokang Pharmaceutical Co., Ltd. Strategic initiatives
Table 105. Suzhou Erye Pharmaceutical Co., Ltd. Profiles
Table 106. Suzhou Erye Pharmaceutical Co., Ltd. Ticarcillin Disodium and Clavulanate Potassium For Injection Product Introduction
Table 107. Suzhou Erye Pharmaceutical Co., Ltd. Ticarcillin Disodium and Clavulanate Potassium For Injection Production (Unit), Revenue (Million USD) (2018-2022)
Table 108. Suzhou Erye Pharmaceutical Co., Ltd. Strategic initiatives